Austria

 

Interview: Arjan Toor, CEO, Cigna Europe

Cigna now describes itself as “a global health service company” rather than an insurer and has reorganised its European operations. Toor has recently been promoted to CEO Europe. He says that the insurer, which has 15% (US$840m) of its revenue in Europe, doesn't want to verticalise through owning primary care providers but wants instead to provide an end-to-end user experience.

FREE BLOG Can one person change a healthcare system?

This week the market is reacting to the news that Unilabs' CEO Jos Lamers is transitioning away from a full-time role. The managed succession, where senior management will still report to Lamers for long-term strategy purposes, means it will retain a familiar face in a figurehead position. Why is this important? Can one person ever mean so much?

A poacher turns gamekeeper: Austrian health care reform     

After 19 years as a health care services expert working as an investment banker, analyst and consultant, Martin Brunninger has returned to his native Austria to become director-general for healthcare and social care. In this role, he is responsible for reforming the entire health and social care system under the new reformist conservative coalition government which came to power in December 2017 and is likely to hold power for a few years. We talk to Brunninger about the likely changes and his change in role.

Liberal fertility markets attract the for-profit sector

Regulation is key in assessing the viability of for-profit fertility markets, according to a recent report from HBI intelligence written after months of discussion with operators in EMEA. More liberal markets are almost always more attractive markets.

TFP buys Vivaneo, plans pan-European fertility network

The Fertility Partnership (TFP) has signed an agreement with Waterland Private Equity to acquire Germany-based fertility provider Vivaneo. Nordic PE owner Impilo now has a wide base to build a truly pan-European network, and, it says a triple-digit millions of euros fertility business.

DACH: Opportunities and pitfalls

A robust DACH session at HBI 2019 reached broad agreement over the most - and least - favourable areas for investment in healthcare in the region, but struggled to agree on the likely implication of the key legislation about to be brought in.

Triple sale kicks off in European IVF market

HBI can reveal that three substantial IVF groups are up for sale who, combined, are active in seven European countries. We reveal potential buyers, valuations and a snapshot of the markets.

Find Us